Target intelligence / Profile preview

Recipient cell membranes and associated uptake machinery

Molecular classification
Other, Cellular structure, Biological process
01

Overview

The term recipient cell membranes and associated uptake machinery refers to the collective biological structures and pathways that facilitate the internalization of extracellular materials into a cell. This system includes the phospholipid bilayer of the plasma membrane and various specialized protein complexes involved in clathrin-mediated endocytosis, caveolae-mediated endocytosis, and macropinocytosis (Alberts et al., Molecular Biology of the Cell). While not a single molecular target, this machinery is the critical gateway for the delivery of advanced therapeutics such as lipid nanoparticles (LNPs), mRNA vaccines, and extracellular vesicles (Sahay et al., Nature Biotechnology, 2010). In many diseases, including cancer and viral infections, these uptake pathways are hijacked to facilitate pathogen entry or to support the metabolic demands of rapidly proliferating cells (Kou et al., Journal of Controlled Release, 2013). Modern drug design, particularly in the field of RNA therapeutics, focuses on optimizing interactions with this machinery to ensure efficient cellular entry and subsequent endosomal escape (Cullis & Hope, Molecular Therapy, 2017).

Other names
Cellular uptake machineryEndocytic pathwaysPlasma membrane transport systemCell entry mechanismsInternalization machinery
02

Mechanism of action

Facilitation of cellular entry via receptor-mediated endocytosis, macropinocytosis, or direct membrane fusion to deliver therapeutic payloads to the cytosol.

03

Biological functions

EndocytosisMacropinocytosisPhagocytosisMembrane fusionIntracellular traffickingSignal transductionNutrient uptake
04

Disease associations

Infection (Viral and bacterial entry)Cancer (Altered nutrient uptake and receptor recycling)Metabolic disordersNeurodegenerative diseases (Protein aggregate uptake)
05

Safety considerations

Off-target delivery to non-intended tissuesEndosomal entrapment leading to drug degradationMembrane toxicity or disruptionImmunogenicity of delivery vehicles (e.g., PEGylation concerns)Lysosomal storage interference
06

Interacting drugs

Patisiran

5 more in the full profile.

07

Biomarkers

Clathrin (CLTC)Caveolin-1 (CAV1)Rab5 (Early endosome marker)Rab7 (Late endosome marker)LAMP1 (Lysosomal marker)Apolipoprotein E (ApoE) levels

Beyond the preview

Go deeper on Recipient cell membranes and associated uptake machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recipient cell membranes and associated uptake machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call